Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3526

Actual shortage: 229 (6%)
Anticipated shortage: 3 (0%)
Avoided shortage: 11 (0%)
Resolved: 3283 (93%)

Discontinuation Reports

366

To be discontinued: 24 (7%)
Discontinued: 342 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

32 (13%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ALENDRONATE/VITAMIN D3 70MG 5600UNIT TABLET Resolved 2017-11-27 2018-07-03 30793
APO-ALENDRONATE/VITAMIN D3 70MG 5600UNIT TABLET Resolved 2018-11-27 2019-01-03 67708
APO-ALENDRONATE/VITAMIN D3 70MG 5600UNIT TABLET Resolved 2020-11-26 2021-04-15 128922
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-05-28 2021-08-03 140066
APO-ALENDRONATE/VITAMIN D3 5600UNIT 70MG TABLET Resolved 2021-06-11 2021-08-03 140767
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-10-22 2021-10-29 147806
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-09-16 2022-10-07 169519
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-11-11 2022-12-05 174343
APO-ALENDRONATE/VITAMIN D3 5600UNIT 70MG TABLET Resolved 2023-02-16 2023-04-21 185033
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2023-03-09 2023-04-21 186572
APO-ALENDRONATE/VITAMIN D3 5600UNIT 70MG TABLET Resolved 2023-05-06 2023-06-16 191892
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-07 2018-01-18 28534
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-29 2020-08-07 121322
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2021-01-18 2021-01-20 131809
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-08-23 2023-09-01 202830
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2023-12-15 209372
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-12 2024-03-22 215973
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-19 2024-06-28 225779
APO-ALLOPURINOL 300MG TABLET Resolved 2019-01-30 2019-02-13 74014
APO-ALLOPURINOL 100MG TABLET Resolved 2020-02-13 2020-04-23 105988

Showing 221 to 240 of 3526

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-FENTANYL MATRIX 25MCG PATCH Discontinued 2018-09-07 2018-09-15 60489
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FLUVOXAMINE 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-FLUVOXAMINE 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110956
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959

Showing 161 to 180 of 366